Filing Details
- Accession Number:
- 0002034863-24-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-08 18:51:09
- Reporting Period:
- 2024-08-05
- Accepted Time:
- 2024-10-08 18:51:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293818 | Opgen Inc | OPGN | Services-Medical Laboratories (8071) | 061614015 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2034863 | Ltd Capital Aei | Po Box 4342 Road Town Tortola D8 00000 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-08-05 | 1,800,000 | $913,265.00 | 1,800,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-08-08 | 600,000 | $454,082.00 | 2,400,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-08-13 | 566,494 | $428,724.00 | 2,966,494 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-08-16 | 3,600,000 | $2,724,490.00 | 6,566,494 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-08-27 | 564,971 | $999,999.00 | 7,131,465 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-08-29 | 514,138 | $999,998.00 | 7,645,603 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series E Convertible Preferred Stock | Disposition | 2024-08-23 | 263,961 | $1,800,000.00 | 633,506 | $2.84 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-08-23 | No | 4 | S | Direct |
Footnotes
- Each share of Series E Preferred Stock is convertible into 2.4 shares of the Issuer's Common Stock.
- The Series E Preferred Stock is perpetual and therefore has no expiration date.